Clayton, Dubilier & Rice to Acquire Cynosure from Hologic
November 20, 2019
Clayton, Dubilier & Rice (CD&R) has agreed to acquire Cynosure, LLC, a leading developer and manufacturer of medical aesthetic treatment systems, from Hologic, Inc. The transaction is a divestiture of Hologic’s aesthetic devices business and will enable CD&R to invest behind Cynosure’s product portfolio, expand sales and marketing, and pursue tuck-in acquisitions to accelerate growth.
- Buyers
- Clayton, Dubilier & Rice
- Targets
- Cynosure, LLC
- Sellers
- Hologic, Inc.
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
The Cynosure Group Acquires Utah Development and Construction to Form Joint Venture Platform With Clyde Capital Group
February 27, 2026
Real Estate
The Cynosure Group acquired Park City-based Utah Development and Construction (UDC) to create a new development platform jointly owned by Clyde Capital Group and Cynosure Elevations, Cynosure’s real estate investment division. The joint venture will focus on developing hospitality and mixed-use projects in premier resort markets across the Intermountain West.
-
Hahn & Company Acquires Cynosure and Merges It with Lutronic to Form Cynosure Lutronic
January 19, 2024
Medical Devices
Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.
-
Clayton, Dubilier & Rice Partners with Vera Whole Health
July 1, 2021
Healthcare Services
Clayton, Dubilier & Rice (CD&R) has entered into an investment partnership with Vera Whole Health to support Vera's expansion of its value-based, primary care-focused model. Terms were not disclosed; existing minority investors Transformation Capital and Archimedes Health Investors will remain as minority stakeholders while CD&R will support growth and board leadership changes.
-
Cynosure Acquires MyEllevate Surgical Suture System
April 30, 2021
Medical Devices
Cynosure, a PE-backed medical aesthetics device company, has agreed to acquire the MyEllevate Surgical Suture System to expand its portfolio of minimally invasive facial rejuvenation solutions. The deal brings the patented ICLED light-guided suture technology and associated disposable surgical kit into Cynosure's product lineup to offer physicians a less-invasive alternative for facial/neck rejuvenation.
-
Clayton, Dubilier & Rice Acquires Huntsworth plc
May 1, 2020
Healthcare Services
Clayton, Dubilier & Rice (CD&R) agreed a recommended cash offer and completed the take-private acquisition of Huntsworth plc for approximately £575 million. CD&R said it will invest in Huntsworth’s healthcare-focused commercialization services—including medical affairs, market access and marketing—to support organic and acquisition-led growth under private ownership.
-
Clayton, Dubilier & Rice Acquires Majority Stake in Sirius Computer Solutions
July 1, 2019
IT Services
Clayton, Dubilier & Rice (CD&R) acquired a majority equity interest in Sirius Computer Solutions from funds affiliated with Kelso & Company. The partnership positions CD&R to support Sirius’ continued growth and expand its managed services, cloud, security and solutions offerings while Joe Mertens remains CEO.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.